News Detail

Home / News / Company News / Goldsite Shines at MEDICA 2025: Innovative IVD Solutions Draw Global Attention

Goldsite Shines at MEDICA 2025: Innovative IVD Solutions Draw Global Attention

Author: Scarlett Publish Time: 2025-11-21 Origin: Site

Inquire

November 21, 2025 (Düsseldorf, Germany) – The world’s most influential medical trade fair, MEDICA 2025, successfully concluded yesterday. Over the course of the four-day event, the Goldsite’s booth (Hall 1 / Booth 1B56) became a hub of activity, attracting professional visitors from over 60 countries and regions across Europe, North America, the Middle East, and Asia. The atmosphere was electric with in-depth discussions, resulting in numerous preliminary cooperation agreements. This enthusiastic response underscores the international market's high recognition of our innovative In Vitro Diagnostic (IVD) solutions.

Goldsite Team

Star Products in the Spotlight: Showcasing Robust Technical Strength

Our core product lines took center stage, presenting comprehensive solutions ranging from central laboratories to Point-of-Care Testing (POCT) scenarios:

Comprehensive HbA1c SolutionsWe showcased a full-process solution for Glycated Hemoglobin (HbA1c) testing.

Lab-Grade HPLC Analyzers (GSH-60 & GSH-50): Beyond delivering the Gold Standard in precision and stability, these analyzers address specific regional needs. We highlighted the developed Hemoglobin Variant Detection Mode and Thalassemia Screening features, specifically designed for high-prevalence regions such as Southeast Asia and the Mediterranean. These features effectively identify common hemoglobin variants to prevent interference with HbA1c results, providing a more comprehensive basis for diabetes diagnosis and anemia differentiation. This capability drew significant attention from experts in those regions.

POCT Innovation (A1C GO):

Continuing our legacy of portability and speed, the A1C GO analyzer, paired with single-dose reagents, significantly expands access to high-quality HbA1c testing for primary care clinics, community screenings, and mobile medical scenarios.

Flagship Specific Protein Analysis

Innovative Release: GPP-100 Specific Protein Analyzer: Designed specifically for primary care and mobile health, the GPP-100 stands out for its lightweight portability and comprehensive test menu. Capable of performing over 20 types of tests—including immune, inflammation, and diabetes markers—it attracted the attention of numerous regional distributors.

Classic Return: Aristo Fully Automated HbA1c AnalyzerAs a classic staple of our portfolio, the Aristo is renowned for its stable performance and highly automated experience, with thousands of units installed domestically. Its presence at MEDICA aimed to demonstrate a high-efficiency, high-quality automated solution for global central laboratories, helping to streamline workflow optimization.

Precision Empowerment: GH-3100 Automated 3-Part Diff Hematology Analyzer

This system supports both whole blood and pre-diluted modes, requiring only micro-samples to complete rapid analysis. With a throughput of dozens of samples per hour, it significantly boosts efficiency for routine screenings in various medical institutions.

Global Compliance: Full Product Line Certification

Quality and compliance are the cornerstones of Goldsite Diagnostics. We are proud to announce that our key exhibited products have obtained CE Certification (EU) and secured registration in multiple target markets, providing a solid foundation for reliable global partnerships.

Regulatory Status of Key Exhibits (As of November 2025):

Product Name	Key Function / Application	Registration Status
GSH-60 HPLC Analyzer	HbA1c Testing (Lab Gold Standard)	EU CE, IFCC/NGSP, NMPA, Kazakhstan, Russia (RZN), Brazil (ANVISA), Multiple SE Asian countries
A1C GO	POCT HbA1c Analyzer (Lab-Grade POCT)	EU CE, IFCC/NGSP, MHRA, NMPA, Middle East, South Korea, Multiple SE Asian & LATAM countries
Aristo	Auto High-throughput Specific Protein Analyzer(Lab)	EU CE, NMPA, MHRA, FDA List, Middle East&Multiple Asian countries
GPP-100	Multi-parameter Specific Protein (Lab-Grade POCT)	EU CE, MHRA, NMPA, FDA List, Middle East&Southeast Asia, Partial LATAM countries
GH-3100	3-Part Diff Hematology Analyzer	EU CE
GBA-1000	Open System Biochemistry Analyzer	EU CE, NMPA, MHRA, FDA List, Middle East&Multiple Asian countries

Future Outlook: Deepening Our Global Strategic Layout

MEDICA 2025 was more than just a product showcase; it was a vital platform for industry exchange and trend analysis. Through face-to-face communication with global clients, we have gained deeper insights into the diverse needs and regulatory trends of different regional markets.

Although the exhibition has concluded, our global journey is just beginning. Goldsite will actively follow up on the valuable leads and feedback gathered during the event to accelerate the implementation of new partnerships. Moving forward, we remain committed to innovation, developing diagnostic products that are closer to clinical needs, and working hand-in-hand with global partners to advance precision medicine for all.

Goldsite Exhibits at MEDICA 2025

Goldsite Team at MEDICA 2025

❏ About Goldsite

Established in 1999 and headquartered in Shenzhen, China, Goldsite Diagnostics Inc. is a leading manufacturer of in vitro diagnostic (IVD) products. We are dedicated to the research, development, manufacturing, sales, and service of clinical testing instruments and reagents. Our product range includes specific proteins, HbA1c, hematology, chemistry, immunofluorescence, and chemiluminescence assays. Known for high manufacturing standards, our products are widely recognized and have successfully entered over 100 countries worldwide.